Clinical Handbook of Insomnia

Expanding on the critical contributions of previous editions, this updated and comprehensive resource covers the latest diagnostic criteria of insomnia. The book is thematically divided into two parts. The first section consists of chapters on nomenclatur

  • PDF / 6,323,913 Bytes
  • 292 Pages / 439.43 x 683.15 pts Page_size
  • 37 Downloads / 175 Views

DOWNLOAD

REPORT


Hrayr P. Attarian Editor

Clinical Handbook of Insomnia Third Edition

CURRENT CLINICAL NEUROLOGY Daniel Tarsy, MD, SERIES EDITOR

More information about this series at http://www.springer.com/series/7630

Hrayr P. Attarian Editor

Clinical Handbook of Insomnia Third Edition

Editor Hrayr P. Attarian Sleep Disorders Center, Department of Neurology Northwestern University Feinberg School of Medicine Chicago, IL, USA

Current Clinical Neurology ISBN 978-3-319-41398-3 ISBN 978-3-319-41400-3 DOI 10.1007/978-3-319-41400-3

(eBook)

Library of Congress Control Number: 2016950594 © Springer International Publishing Switzerland 2003, 2010, 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG Switzerland

Preface

Insomnia is the second most common complaint, after pain, in the primary care setting. Chronic insomnia, as defined by the 2015 edition International Classification of Sleep Disorders (ICSD 3), affects 9–12 % of the population, is a risk factor for significant psychiatric morbidity, and is associated with higher mortality in men. Insomnia also leads to overutilization of health care services, decreased productivity in the workplace, more accidents, and more absenteeism from work. All this costs about $100 billion annually. Hence, persistent insomnia is both a public health and an economic problem. Chronic insomnia is a complex illness with many comorbidities each, naturally, requiring a different method of evaluation and treatment. Patients with insomnia frequently self-treat with alcohol or over-the-counter medications. There is very little scientific evidence for the efficacy of these medications in insomnia and there is growing evidence of significant long-term adverse effects with their use. Additionally, those taking these medications may suffer impaired daytime functioning caused by lingering feelings of sedation. Newer data also p